PL438131A1 - Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application - Google Patents

Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application

Info

Publication number
PL438131A1
PL438131A1 PL438131A PL43813121A PL438131A1 PL 438131 A1 PL438131 A1 PL 438131A1 PL 438131 A PL438131 A PL 438131A PL 43813121 A PL43813121 A PL 43813121A PL 438131 A1 PL438131 A1 PL 438131A1
Authority
PL
Poland
Prior art keywords
sub
methoxy
ethoxy
substituted
tetrahydropyridin
Prior art date
Application number
PL438131A
Other languages
Polish (pl)
Inventor
Agnieszka Anna Kaczor
Magda Kondej
Tomasz M. Wróbel
Dariusz Matosiuk
María De Los Ángeles Castro Pérez
Antón Leandro Martínez Rodrígues
María Isabel Loza García
Original Assignee
Uniwersytet Medyczny W Lublinie
Universidade De Santiago De Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Universidade De Santiago De Compostela filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL438131A priority Critical patent/PL438131A1/en
Publication of PL438131A1 publication Critical patent/PL438131A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Przedmiotem wynalazku są pochodne 5-podstawione-3-(1-aryloaliklo-1,2,3,6-tetrahydropirydyn-4-ylo)-1H-indolu o wzorze ogólnym 1, gdzie R<sub>1</sub> oznacza podstawnik fenyloctylowy, natomiast R<sub>2</sub> oznacza podstawnik metoksylowy lub R<sub>1</sub> oznacza podstawnik 4-metoksylenyloetylowy, natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik 4-fluorofenyloetylowy, natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik propylofenylowy, natomiast R<sub>2</sub> oznacza podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik butylofenylowy, natomiast R<sub>2</sub> oznacza podstawnik metoksylowi lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik (2-okso-1H-benzo[b]oksin-3-ylo)metylo natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy oraz pochodne 5-podstawione-3-(1-alkilo-1,2,3,6-tetrahydropirydyn-4-ylo)-1H-indolu o wzorze ogólnym 1, gdzie R<sub>1</sub> oznacza podstawnik 2-metylopropylowy natomiast R<sub>2</sub> oznacza wodór lub podstawnik metoksylowy lub podstawnik etoksylowy lub R<sub>1</sub> oznacza podstawnik izopropylowy natomiast R<sub>2</sub> oznacza podstawnik metoksylowy lub podstawnik etoksylowy. Związki będące przedmiotem wynalazku otrzymuje się w reakcji 5-podstawionych indoli z 1-alkiloarylo- lub 1-alkilopodstawionymi pochodnymi piperydyn-4-onu w metanolu w obecności wodorotlenku potasu. Reakcję prowadzi się przez 18 godzin w temperaturze wrzenia rozpuszczalnika. Mieszaninę reakcyjną pozostawia do swobodnej krystalizacji lub oziębia się, a po ochłodzeniu otrzymuje się osad produktu. Produkt reakcji oczyszcza się przez przemycie wodą, metanolem, eterem i rekrystalizuje się z odpowiedniego rozpuszczalnik,. korzystnie metanolu lub DMF albo oczyszcza metodami chromatograficznymi, korzystnie za pomocą chromatografii kolumnowej (żel krzemionkowy, gradient 2-5% bezw. NH<sub>3</sub> w MeOH/DCM). Związki według wynalazku będące wielocelowymi ligandami monoamin, w szczególności receptora dopaminowego D<sub>2</sub> oraz receptorów serotoninowych 5-HT<sub>1A</sub> i 5-HT<sub>2A</sub>, do zastosowania w leczeniu chorób psychicznych, w szczególności schizofrenii, choroby afektywnej dwubiegunowej i depresji.The subject of the invention are 5-substituted-3-(1-arylaalkyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives of the general formula 1, where R<sub>1</sub> is a substituent phenylethyl and R<sub>2</sub> is methoxy or R<sub>1</sub> is 4-methoxylenylethyl and R<sub>2</sub> is hydrogen or methoxy or ethoxy or R<sub>1</sub> is 4-fluorophenylethyl and R<sub>2</sub> is hydrogen or methoxy or ethoxy or R<sub>1</sub> is propylphenyl and R< sub>2</sub> means methoxy or ethoxy or R<sub>1</sub> means butylphenyl and R<sub>2</sub> means methoxy or ethoxy or R<sub>1< /sub> means (2-oxo-1H-benzo[b]oxin-3-yl)methyl and R<sub>2</sub> means hydrogen or methoxy or ethoxy and 5-substituted derivatives ne-3-(1-alkyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole of the general formula 1, where R<sub>1</sub> is a 2-methylpropyl substituent and R< sub>2</sub> is hydrogen or methoxy or ethoxy or R<sub>1</sub> is isopropyl and R<sub>2</sub> is methoxy or ethoxy. The compounds of the invention are prepared by reacting 5-substituted indoles with 1-alkylaryl- or 1-alkyl-substituted piperidin-4-one derivatives in methanol in the presence of potassium hydroxide. The reaction is carried out for 18 hours at the reflux temperature of the solvent. The reaction mixture is allowed to crystallize freely or is cooled and, on cooling, a precipitate of the product is obtained. The reaction product is purified by washing with water, methanol, ether and recrystallized from a suitable solvent. preferably methanol or DMF, or purified by chromatographic methods, preferably by column chromatography (silica gel, gradient 2-5% anhydrous NH<sub>3</sub> in MeOH/DCM). Compounds of the invention which are multitarget ligands of monoamines, in particular the dopamine D<sub>2</sub> and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, for use in in the treatment of mental illnesses, in particular schizophrenia, bipolar disorder and depression.

PL438131A 2021-06-11 2021-06-11 Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application PL438131A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL438131A PL438131A1 (en) 2021-06-11 2021-06-11 Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438131A PL438131A1 (en) 2021-06-11 2021-06-11 Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application

Publications (1)

Publication Number Publication Date
PL438131A1 true PL438131A1 (en) 2022-12-12

Family

ID=84441507

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438131A PL438131A1 (en) 2021-06-11 2021-06-11 Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application

Country Status (1)

Country Link
PL (1) PL438131A1 (en)

Similar Documents

Publication Publication Date Title
ES2437755T3 (en) Intermediates for thienopyrazole derivatives that have PDE 7 inhibitory activity
JP6770580B2 (en) Pyrrolopyrimidine 5-membered ring aza cyclic derivative and its use
CA3009669C (en) Bruton&#39;s tyrosine kinase inhibitors
Qin et al. Metal-free catalyzed oxidative trimerization of indoles by using TEMPO in air: a biomimetic approach to 2-(1 H-indol-3-yl)-2, 3′-biindolin-3-ones
NO316564B1 (en) Process for the preparation of imidazoquinolinamines
AU2013276519B2 (en) 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
CA2873925A1 (en) 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
CA2895430A1 (en) Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents
JP2021532100A (en) Further Substituted Triazoloquinoxaline Derivatives
JP2021532103A (en) Substituted triazoloquinoxaline derivative
JP2021511299A (en) New processes and intermediates for preparing soluble guanylate cyclase stimulants
JPH01268679A (en) Production of 1-cyclopropyl-quinolone carboxylic acid and its derivative
PL438131A1 (en) Derivatives of 5-substituted-3-(1-alkilaryl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole and 5-substituted-3-(1-alkil-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, the method of their preparation and their application
AU2011308256A1 (en) Novel method of preparing benzoimidazole derivatives
CN104016969A (en) N2-substituted 1,2,3-triazole derivative for Cu (I) ligand as well as preparation method and application of N2-substituted 1,2,3-triazole derivative
JP6256484B2 (en) Method for producing pyridazine compound
US20050245750A1 (en) Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
PL438132A1 (en) Substituted derivatives of 3-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, method of their preparation and their application
TW402593B (en) Process for preparing 7-amincocarbonyl-tetrabenzodiazepines and intermediates
Misra et al. In search of imidazo [1, 2-a] pyridine derivatives exhibiting resistance for catalytic hydrogenation
Raghavender et al. Synthesis, Antibacterial Activity, and Cytotoxicity of Newly Synthesized N-Substituted 5, 6-Dimethoxy-1 H-indole Derivatives
KR101432427B1 (en) Efficient synthesis of 3-hydroxy-2-oxindol derivatives by i_2 catalyzed reaction
PL438130A1 (en) Derivatives of 5-substituted-3-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, method of their preparation and their applicatione
CA2461572C (en) Polycyclic compounds having anti-tumor activity
Kovalskiy et al. Synthesis of 7-(3-piperidyl)-[1, 6] naphthyridine and 7-(4-pipe-ridyl)[1, 6] naphthyridine.